Bacterial FtsZ inhibition by benzo[d]imidazole-2-carboxamide derivative with anti-TB activity

Author:

Dhameliya Tejas M12ORCID,Tiwari Rishu3,Patel Kshitij I1,Vagolu Siva Krishna4,Panda Dulal3,Sriram Dharmarajan4,Chakraborti Asit K15ORCID

Affiliation:

1. Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research, Sector 67, Sahibzada Ajit Singh Nagar, Punjab, 160 062, India

2. Department of Pharmaceutical Chemistry and Quality Assurance, L. M. College of Pharmacy, Navrangpura, Ahmedabad, Gujarat, 380 009, India

3. Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, Maharashtra, 400 076, India

4. Department of Pharmacy, Birla Institute of Technology and Science – Pilani, Hyderabad Campus, Jawahar Nagar, Hyderabad, 500 078, India

5. School of Chemical Sciences, Indian Association for the Cultivation of Science, Jadavpur, Kolkata, West Bengal, 700 032, India

Abstract

Aims: The present study aimed to assess the mode of action of previously reported anti- Mycobacterium tuberculosis benzo[ d]imidazole-2-carboxamides against FtsZ along with their antibacterial potential. Materials & methods: The anti-mycobacterial action of benzo[ d]imidazole-2-carboxamides against FtsZ was evaluated using inhibition of Bacillus subtilis 168, light scattering assay, circular dichroism spectroscopy, in silico molecular docking and molecular dynamics simulations. Results & conclusion: Three compounds (1k, 1o and 1e) were active against isoniazid-resistant strains. Four compounds (1h, 1i, 1o and 4h) showed >70% inhibition against B. subtilis 168. Compound 1o was the most potent inhibitor (91 ± 5% inhibition) of  B. subtilis 168 FtsZ and perturbed its secondary structure. Molecular docking and molecular dynamics simulation of complexed 1o suggested M. tuberculosis FtsZ as a possible target for antitubercular activity.

Publisher

Future Science Ltd

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Reference60 articles.

1. Robert Koch

2. WHO. Global tuberculosis report 2021 (2021). www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2021

3. Oxazolidinones as Anti-tubercular Agents: Discovery, Development and Future Perspectives

4. Tuberculosis

5. New drugs and perspectives for new anti-tuberculosis regimens

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3